✦ LIBER ✦

BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP

✍ Scribed by IVERSEN, PETER; TYRRELL, CHRIS J.; KAISARY, AMIR V.; ANDERSON, JOHN B.; VAN POPPEL, HEIN; TAMMELA, TEUVO L.J.; CHAMBERLAIN, MICHAEL; CARROLL, KEVIN; MELEZINEK, IVAN

Book ID: 120529912
Publisher: Lippincott Williams and Wilkins
Year: 2000
Tongue: English
Weight: 122 KB
Volume: 164
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(05)67032-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bicalutamide Monotherapy Compared with C

Bicalutamide Monotherapy Compared with Castration in Patients with Nonmetastatic Locally Advanced Prostate Cancer: 6.3 Years of Follow-up

✍ Timothy Gilligan; William Oh 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Tolerability, efficacy and pharmacokinet

Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration

✍ CHRIS J. TYRRElL; PETER IVERSEN; TEUVO TAMMELA; JOHN ANDERSON; THOMAS BJÖRK; AMI 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Casodex (bicalutamide) 150-mg monotherap

Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years

✍ Peter Iversen; Chris J. Tyrrell; Amir V. Kaisary; John B. Anderson; Luc Baert; T 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 871 KB

A controlled trial of bicalutamide versu

A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer

✍ Gregory T. Bales; Gerald W. Chodak 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 611 KB

896 PUBLICATION Survival advantage and m

896 PUBLICATION Survival advantage and modest cost associated with bicalutamide combination therapy compared with castration alone in patients with advanced prostate cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Antiandrogen monotherapy in patients wit

Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years

✍ Peter Iversen; David G. McLeod; William A. See; Thomas Morris; Jon Armstrong; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB